UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001974
Receipt number R000002387
Scientific Title A multi-center prospective trial comparing Functional Dyspepsia patients with or without Metabolic Syndrome treated with omeprazole
Date of disclosure of the study information 2009/05/20
Last modified on 2019/12/04 22:03:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multi-center prospective trial comparing Functional Dyspepsia patients with or without Metabolic Syndrome treated with omeprazole

Acronym

DMETS study

Scientific Title

A multi-center prospective trial comparing Functional Dyspepsia patients with or without Metabolic Syndrome treated with omeprazole

Scientific Title:Acronym

DMETS study

Region

Japan


Condition

Condition

Functional Dyspepsia

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the efficacy of omeprazole in functional dyspepsia with or without metabolic syndrome.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Severity of dyspeptic symtoms by Gastrointestinal Symptom Rating Scale(GSRS)

Key secondary outcomes

Patients' Background
QOL evaluation by SF-36
Anti-H. pylori IgG
Serum pepsinogen I, pepsinogen II


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

omeprazole

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with functional dyspepsia diagnosed according to the Rome III classification.

Key exclusion criteria

1. Endoscopic finding such as reflux esophagitis (> grade A) and erosive gastritis.
2. Patients with past history of gastrectomy
3. NSAIDs or low-dose aspirin -related dyspepsia
4. Patients treated with proton pump inhibitors(PPI), H2 receptor antagonists(H2RAs), prokinetic drugs, anticholinergic drugs, antidepressant drugs, antianxiety drugs (within 14 days prior to the screening visit)
5. Patients with organic disease in the brain or with psychological disorders
6. Patients with alcoholics or with drug dependence
7. Severe endocrine disease including hyperthyroidism
8. Severe diseases in heart, liver and kidney. Severe infectious or hemotological diseases
9. Drug allegy for omeprazole
10. Expectant mother, mother with breast-feeding
11. Other not applicable patients recognized by a doctor

Target sample size

210


Research contact person

Name of lead principal investigator

1st name MAMORU
Middle name
Last name ITO, M.D., Ph.D.

Organization

Okayama Saiseikai General Hospital

Division name

Internal Medicine

Zip code

700-0021

Address

2-25 Kokutaicho, Kita-Ku, Okayama 700-0021, JAPAN

TEL

086-252-2211

Email

mitohxxx@gmail.com


Public contact

Name of contact person

1st name MAMORU
Middle name
Last name ITO, M.D., Ph.D.

Organization

Okayama Saiseikai General Hospital

Division name

Internal Medicine

Zip code

700-0021

Address

2-25 Kokutaicho, Kita-Ku, Okayama 700-0021, JAPAN

TEL

086-252-2211

Homepage URL


Email

mitohxxx@gmail.com


Sponsor or person

Institute

Office of DMETS study

Institute

Department

Personal name



Funding Source

Organization

Social Welfare Organization Saiseikai Imperial Gift Foundation, Inc.

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Okayama Saiseikai General Hospital Institutional Review Board

Address

2-25 Kokutaicho, Kita-Ku, Okayama 700-0021, JAPAN

Tel

086-252-2211

Email

chiken-hp@okayamasaiseikai.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 05 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2009 Year 04 Month 01 Day

Date of IRB

2009 Year 04 Month 09 Day

Anticipated trial start date

2009 Year 06 Month 01 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 05 Month 16 Day

Last modified on

2019 Year 12 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002387


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name